Back to Rankings

TCRX

TScan TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
TCRX vs peer average
18/100
TCRX vs. peer average (F vs. C)
Grade spread
A 1 · B 3 · C 1 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IMA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $64.36M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerIMAImageneBio
TCRX
TScan Therapeutics
IMA
ImageneBio
Grade
F
C
Momentum
10
58
Value
58
57
Sentiment
-
44
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs IMA

TCRX / IMA
Grade Position
Below peers
TCRX vs. peer average (F vs. C)
18/100
Momentum
10
IMA
Value
58
TCRX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TCRX
1
IMA
ImageneBio Inc Common
C
60/100
-2
2
ANVS
Annovis Bio Inc Common
F
20/100
Even
3
PDSB
PDS Biotechnology Corp Common
B
80/100
-3
4
PMVP
PMV Pharmaceuticals Inc Common
D
40/100
-1
5
SCLX
Scilex Holding Co Common
F
20/100
Even
IMA is the first peer returned for this comparison set.